PRELIMINARY PROGRAM

CME Information
CME Accreditation and Designation
The China Interventional Therapeutics is accredited by the
Accreditation Council for Continuing Medical Education of
Ministry of Health of China to provide continuing medical
education for physicians. This education activity has been
designated for 8 national category-1 CME Credits in China.
Six hours of physician participation in CIT equals 1 credit.
Documentation of awarded credit is provided for registered
attendees in exchange for completed activity evaluations.
Certificates of attendance are provided to all registered
attendees. The following activities are not included in the
official CIT CME program: luncheon workshops, evening
symposia and interventional vascular simulation sessions.
Learning Objectives
By the end of the congress, participants should be able to
Relate the results from important clinical trials and
evidencebased medicine that guide the management of
patients with atherosclerosis and structural heart disease
Integrate new interventional techniques and procedures to
the care of patients with complex coronary artery disease,
peripheral vascular disease, structural heart disease, and
heart rhythm
Integrate appropriate pharmacological management in
the care of patients undergoing diagnostic angiography
and interventional therapies before, during, and after
catheterization
Distinguish between new interventional technologies and
propose their appropriate applications to patients with
cardiovascular disease
Target Audience
This congress is designed for interventional cardiologists,
radiologists, clinical cardiologists, basic scientists, vascular
medicine specialists, surgeons, and other health care
professionals with a special interest in the field of
interventional vascular therapy and medicine.
Activity Evaluation
Evaluation by questionnaire will address content,
presentation, possible bias, and future educational needs.
Disclosure Statement
It is the policy of the Chinese Medical Association to ensure
balance, independence, objectivity, and scientific rigor in all
of its sponsored educational programs. Commercial support
from industry does not influence educational content,
faculty selection, and/or faculty presentations, and, therefore,
does not compromise the scientific integrity of the
educational activity. Discussion of off-label product usage,
and/or off-label product use during live cases, is made at the
sole discretion of the faculty. Off-label product discussion
and/or off-label product use is not endorsed by the Chinese
Medical Association or the course directors for this activity.
Faculty participating in continuing medical education
activities sponsored by the Chinese Medical Association are
required to disclose to the program audience any real or
apparent conflict of interest related to the content of their
presentation(s). Faculty not complying with this policy are
not permitted to participate in this activity.
Program Sponsorship and Support
The congress is sponsored by Chinese Medical Association,
CIT Board of Directors, Chinese Society of Cardiology,
and Cardiovascular Research Foundation / Transcatheter
Cardiovascular Therapeutics (TCT), and partially funded
through educational grants from commercial supporters.
The CIT strives to ensure that its programs are as educational
as possible and free from bias. To support this endeavor, CIT
director and co-directors create organizing and scientific
committees to assist in educational content development
and content oversight for live cases, concurrent sessions,
case reviews, workshops, and scientific symposia. These
sessions are developed without influence from commercial
supporters.
08